MTST (MetaStat) Pretax Margin %: % (As of Feb. 2018)


What is MetaStat Pretax Margin %?

MetaStat MTST Pretax Margin % is % as of Feb. 2018.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. MetaStat's Pre-Tax Income for the three months ended in Feb. 2018 was $-0.97 Mil. MetaStat's Revenue for the three months ended in Feb. 2018 was $0.00 Mil. Therefore, MetaStat's pretax margin for the quarter that ended in Feb. 2018 was %.

The historical rank and industry rank for MetaStat's Pretax Margin % or its related term are showing as below:


MTST's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

MetaStat  (OTCPK:MTST) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

MetaStat Pretax Margin % Related Terms

MetaStat Pretax Margin % Historical Data

* Premium members only.

The historical data trend for MetaStat's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat Pretax Margin % Chart

MetaStat Annual Data
Trend Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -13,830.43

MetaStat Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -1,200.00 0.00 0.00 0.00

MTST vs OBMP, NSPX, ATRX: Pretax Margin % Comparison

For the Biotechnology subindustry, MetaStat's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MetaStat Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MetaStat's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where MetaStat's Pretax Margin % falls into.


MetaStat Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

MetaStat's Pretax Margin for the fiscal year that ended in Feb. 2018 is calculated as

Pretax Margin=Pre-Tax Income (A: Feb. 2018 )/Revenue (A: Feb. 2018 )
=-3.181/0.023
=-13,830.43 %

MetaStat's Pretax Margin for the quarter that ended in Feb. 2018 is calculated as

Pretax Margin=Pre-Tax Income (Q: Feb. 2018 )/Revenue (Q: Feb. 2018 )
=-0.972/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
MetaStat (MTST) has a Pretax Margin % of % as of Feb. 2018. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on MetaStat and its competitors.
Is MetaStat's Pretax Margin % too high?
MetaStat's current Pretax Margin % is %.
How does MetaStat's Pretax Margin % compare to OBMP and NSPX?
MetaStat's Pretax Margin % of % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on MetaStat and its competitors. MetaStat's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For MetaStat (MTST), the current Pretax Margin % is % as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.